Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73+0.00 (0.00%)
Close on Nov 18, 2026Market cap $300.72MP/E –Yield –
Sanara MedTech r&d expenses
Research and development expenses are spending on new products and technology.
Sanara MedTech's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.98M, up 35.5% year over year. For fiscal 2025 it was $5.07M, up 79.3% from the year before. The highest annual figure on record is $5.07M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.07M | +79.3% |
| FY2024 | Dec 31, 2024 | $2.83M | -31.5% |
| FY2023 | Dec 31, 2023 | $4.13M | +22.7% |
| FY2022 | Dec 31, 2022 | $3.37M | +502.7% |
| FY2021 | Dec 31, 2021 | $558.70K | +1290.2% |
| FY2020 | Dec 31, 2020 | $40.19K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.15M | +9.2% |
| Q1 FY2026 | Mar 31, 2026 | $759.59K | -20.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.04M | +130.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.03M | +31.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.06M | +7.2% |
| Q1 FY2025 | Mar 31, 2025 | $950.36K | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $883.40K | +35.6% |
| Q3 FY2024 | Sep 30, 2024 | $783.84K | -20.5% |
| Q2 FY2024 | Jun 30, 2024 | $985.65K | -16.3% |
| Q1 FY2024 | Mar 31, 2024 | $946.30K | -28.2% |
| Q4 FY2023 | Dec 31, 2023 | $651.52K | -37.0% |
| Q3 FY2023 | Sep 30, 2023 | $986.45K | -7.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.18M | +10.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.32M | +543.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.03M | +243.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.06M | +2875.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.07M | +926.1% |
| Q1 FY2022 | Mar 31, 2022 | $204.64K | +73.1% |
| Q4 FY2021 | Dec 31, 2021 | $300.84K | +931.4% |
| Q3 FY2021 | Sep 30, 2021 | $35.67K | +223.7% |
| Q2 FY2021 | Jun 30, 2021 | $103.98K | +150.5% |
| Q1 FY2021 | Mar 31, 2021 | $118.21K | +2594.6% |
| Q4 FY2020 | Dec 31, 2020 | $29.17K | – |
| Q3 FY2020 | Sep 30, 2020 | $11.02K | – |
| Q2 FY2020 | Jun 30, 2020 | $41.52K | – |
| Q1 FY2020 | Mar 31, 2020 | $4.39K | – |
See a number that looks wrong?